IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Edwards Lifesciences Corp

CUSIP: 28176E124 | 2 institutional holders

Quarters

Q4 2021Q1 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2021

Kathmere Capital Management, LLC2,880
0.0% of portfolio›$373
StyleTurnoverLocationFiled
Kathmere Capital Management, LLC
2,880$3730.0%ETFLowWayne, PA2022-01-27